LINC02381-ceRNA exerts its oncogenic effect through regulation of IGF1R signaling pathway in glioma Hossein NematiMasoumeh Fakhre-TahaBahram M. Soltani Laboratory Investigation 23 April 2022 Pages: 1 - 13
The Clinical Frailty Scale as predictor of overall survival after resection of high-grade glioma Julia KlingenschmidAleksandrs KrigersChristian F. Freyschlag Clinical Study Open access 25 April 2022 Pages: 15 - 22
High dose image-guided, intensity modulated radiation therapy (IG-IMRT) for chordomas of the sacrum, mobile spine and skull base: preliminary outcomes Andre Tsin Chih ChenCarlos Bo Chur HongWilliam Gemio Jacobsen Teixeira Research 22 April 2022 Pages: 23 - 31
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors Andrew B. DeAtkineMoaaz AbdelrashidL. Burt Nabors Clinical Study 20 April 2022 Pages: 33 - 40
Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas Natasha IronsideHarrison SnyderJason P. Sheehan Clinical Study 24 April 2022 Pages: 41 - 50
The Clinical Frailty Scale as useful tool in patients with brain metastases Johannes KerschbaumerAleksandrs KrigersChristian F. Freyschlag Research Open access 13 April 2022 Pages: 51 - 57
Preoperative antiepileptic drug prophylaxis for early postoperative seizures in supratentorial meningioma: a single-center experience Qing CaiYingxi WuDayun Feng Research 17 April 2022 Pages: 59 - 67
Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists Leah E. WalshLaura C. PolacekEli L. Diamond Research 18 April 2022 Pages: 69 - 79
LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas Cas VanderheijdenThomas VaessenGovert Hoogland Laboratory Investigation Open access 04 May 2022 Pages: 81 - 88
Comparison of the quality of death between primary malignant brain tumor patients and other cancer patients: results from a nationwide bereavement survey in Japan Maho AoyamaKento MasukawaMitsunori Miyashita Research 18 April 2022 Pages: 89 - 97
Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive outcomes Christelle NillesDaniel DelgadilloCaroline Houillier Research 21 April 2022 Pages: 99 - 109
Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients Vasileios K. KavouridisKeith L. LigonJ. Bryan Iorgulescu Clinical Study 26 April 2022 Pages: 111 - 116
Predictors of survival and time to progression following operative management of intramedullary spinal cord astrocytomas Andrew M. HershAlbert AntarDaniel M. Sciubba Research 11 May 2022 Pages: 117 - 127
Correction to: Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma Naiyuan ShaoJiahao MaoQing Lan Correction Open access 04 May 2022 Pages: 129 - 129